Prevalence and risk factors of diabetic neuropathy in Qassim, Saudi Arabia

Almohisen, Amal; Almuhaysen, Lama M; Alhatlany, Khawlah K; Alghalth, Reham H; Almutairi, Ashwaq M; Almarzogy, Fatmah A; Alghasham, Haneen A; Almohaysen, Ghaida M

doi:10.5455/mjhs.2020.02.004

Cited by 5 publications

(5 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similarly, in another cross-sectional study carried out in Saudi Arabia in 2014, which included 552 patients with diabetes, insulin use was found to be associated with DN [ 21 ]. Another cross-sectional study carried out in Qassim, Saudi Arabia in 2020 on 374 patients with diabetes showed that a multi-drug approach and insulin use, in particular, was associated with a high risk of developing DN [ 11 ].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Diabetic Polyneuropathy in Type 1 and Type 2 Diabetes Mellitus: A Cross-Sectional Study

Hindi¹,

Almusally²,

Bawareth³

et al. 2022

Cureus

View full text Add to dashboard Cite

Background: Diabetes mellitus (DM) is one of the three most common chronic diseases worldwide. This study aimed to determine the prevalence of diabetic polyneuropathy (DPN) among patients with diabetes.Method: This cross-sectional study was carried out on DM patients who visited King Abdulaziz University Hospital (KAUH) between August 2021 and February 2022. We used the Michigan Neuropathy Screening Instrument (MNSI) questionnaire to determine if the patients had DN. In addition, we used the Global Physical Activity Questionnaire (GPAQ) to assess the level of physical activity (PA) in these DM patients.Results: A total of 336 patients consented to participate in the study. We found a DN prevalence of 23.8% amongst DM patients treated at the KAUH. In addition, the prevalence of DN amongst T1DM and T2DM patients was found to be 16% and 24.4%, respectively. Furthermore, we found that 65% of DM patients developed complications, with a significant correlation observed between the duration of DM and the development of complications. However, patient age and sex were non-statistically significantly correlated with the development of complications. Analysis of the GPAQ showed that among the 249 patients who completed the questionnaire, none had a high physical activity level, while 4% and 96% had moderate and low physical activity levels, respectively. No association was found between physical activity and patients' age, sex, type of DM, duration of DM, and development of complications.Conclusion: DN prevalence amongst DM patients treated at KAUH was 23.8%. The duration of diabetes was found to be a risk factor for DN. However, patient age and sex were non-statistically significantly associated with DN.

show abstract

Section: Discussionmentioning

confidence: 99%

“…The Michigan Neuropathy Screening Instrument (MNSI) was used to evaluate DN in DM patients in the second and third sections of the questionnaire. The Arabic version of the MNSI was used and a total score of four or more was considered abnormal [10][11][12]. MNSI questions on medical history had to be answered with a 'Yes' or a 'No'.…”

Section: Methodsmentioning

confidence: 99%

Diabetic Polyneuropathy in Type 1 and Type 2 Diabetes Mellitus: A Cross-Sectional Study

Hindi¹,

Almusally²,

Bawareth³

et al. 2022

Cureus

View full text Add to dashboard Cite

show abstract

“…1). The screening of titles and abstracts based on the exclusion criteria resulted in the removal of 123 articles Finally, 11 crosssectional studies [8,24,31,32,33,34,35,36,37,38,39] and 1 prospective study [40]. were assessed for their quantitative analysis (Fig.…”

Section: Study Identification and Selectionmentioning

confidence: 99%

Magnitude of diabetic peripheral neuropathy in Saudi Arabia: a systematic review and meta-analysis

et al. 2022

View full text Add to dashboard Cite

Background Diabetic peripheral neuropathy (DPN), due to its potential for causing morbidity and disability from foot ulcers and amputations, is increasingly becoming a source of concern in Saudi Arabia and worldwide. However, wide variability exists in the prevalence of DPN reported in previous studies in Saudi Arabia, limiting the utility of existing data in national public health policy. Therefore, the aim of this study was to systematically evaluate the magnitude of DPN in patients living with DM in Saudi Arabia in order to inform policymakers during the implementation of appropriate preventive and treatment strategies for DPN. Methods PubMed, Google Scholar, African Journals Online, Scopus, Web of Science, Embase, and Wiley Online Library were searched systematically to acquire relevant articles based on preset criteria. We evaluated heterogeneity and publication bias and employed a random-effects model to estimate the pooled prevalence of DPN from the included studies. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines in conducting the meta-analysis. Analysis was performed using the STATA Version 12 software. Results Twelve studies with a total of 4,556 participants living with DM, of whom 2,081 were identified as having DPN were included in the meta-analysis. The overall prevalence of DPN was 39% (95% CI [30%, 49%]). Subgroup analysis based on diagnostic method showed that prevalence estimates for DPN using screening questionnaires and clinical examination were 48% (95% CI [46%, 50%]) and 40% (95% CI: [38%, 42%]), respectively, while the estimated prevalence using nerve conduction studies was 26% (95% CI [15%, 36%]). Conclusion This study showed a high magnitude of DPN in Saudi Arabia (39%), thus highlighting the need for sustained efforts to reduce the prevalence of diabetes mellitus and DPN in the kingdom.

show abstract

“…After a detailed evaluation, 23 articles were excluded due to a lack of usable data and other reasons (Figure 1). Finally, 11 cross-sectional studies 8,24,[31][32][33][34][35][36][37][38][39] and 1 prospective study 40 were assessed for their quantitative analysis (Figure 1). Three additional studies [41][42][43] were removed due to their retrospective design.…”

Section: Study Identi Cation and Selectionmentioning

confidence: 99%

Magnitude of Diabetic Neuropathy in Saudi Arabia: A Systematic Review and Meta-Analysis

Owolabi

Alghamdi

Adamu

et al. 2022

Preprint

View full text Add to dashboard Cite

Background: Diabetic peripheral neuropathy (DPN), due to its potential for causing morbidity and disability from foot ulcers and amputations, is increasingly becoming a source of concern in Saudi Arabia and worldwide. However, wide variability exists in the prevalence of DPN reported in previous studies in Saudi Arabia, limiting the utility of existing data in national public health policy. Therefore, this study aimed to estimate the magnitude of DPN in people living with diabetes mellitus in Saudi Arabia.Methods: PubMed, Google Scholar, African Journals OnLine, Scopus, Web of Science, Embase, and Wiley Online Library were searched systematically to acquire relevant articles based on preset criteria. We evaluated heterogeneity and publication bias and employed a random-effects model to estimate the pooled prevalence of DPN from the included studies. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines in conducting the meta-analysis. Analysis was performed using the STATA Version 12 software.Results: Twelve studies with a total of 4,556 participants were included in the meta-analysis. The overall prevalence of DPN was 39% (95% CI [30%, 49%]). Subgroup analysis based on diagnostic method showed that prevalence estimates for DPN using screening questionnaires and clinical examination were 48% (95% CI [46%, 50%]) and 40% (95% CI: [38%, 42%]), respectively, while the estimated prevalence using nerve conduction studies was 26% (95% CI [15%, 36%]). Conclusion: This study showed a high magnitude of DPN in Saudi Arabia (39%), thus highlighting the need for sustained efforts to reduce the prevalence of diabetes mellitus and DPN in the kingdom.

show abstract

Prevalence and risk factors of diabetic neuropathy in Qassim, Saudi Arabia

Cited by 5 publications

References 0 publications

Diabetic Polyneuropathy in Type 1 and Type 2 Diabetes Mellitus: A Cross-Sectional Study

Diabetic Polyneuropathy in Type 1 and Type 2 Diabetes Mellitus: A Cross-Sectional Study

Magnitude of diabetic peripheral neuropathy in Saudi Arabia: a systematic review and meta-analysis

Magnitude of Diabetic Neuropathy in Saudi Arabia: A Systematic Review and Meta-Analysis

Contact Info

Product

Resources

About